China: MicuRX Pharamaceuticals lists on Star Market

Legend Capital portfolio company MicuRx Pharmaceuticals, a biopharmaceutical company focusing on therapeutics for infectious diseases, has listed on Shanghai’s Star Market. MicuRx Pharmaceuticals issued 130 million shares, accounting for 19.84% of the total share capital after the issuance. The total amount of funds raised is expected to be about Rmb960m (US$142m) at the issue price…

You must be a HMI Subscriber to view this content.

Subscribe Now »